Oxitropium bromide

European Pharmacopoeia (EP) Reference Standard

Empirical Formula (Hill Notation):
CAS Number:
Molecular Weight:


pharmaceutical primary standard





Featured Industry

Pharmaceutical (small molecule)



storage temp.




InChI key


General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.


Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.


Other Notes

Sales restrictions may apply.
Certificate of Analysis
Certificate of Origin
Hiroshi Kanazawa et al.
Chest, 125(4), 1368-1371 (2004-04-14)
The interaction between chronic hepatitis C virus (HCV) infection and bronchial asthma is of considerable interest. This study was designed to examine whether differences in airway responses to an inhaled anticholinergic agent exist between asthmatic patients with and without active...
Efficacy of inhaled anticholinergics and anesthesia in treatment of a patient in status asthmaticus.
Hirokazu Arakawa et al.
The Journal of asthma : official journal of the Association for the Care of Asthma, 39(1), 77-80 (2002-03-09)
A Castagnaro et al.
La Radiologia medica, 113(1), 43-55 (2008-03-14)
Airway-wall remodelling may result in reduced airway distensibility in bronchial asthma. This study evaluated the baseline airway calibre and distensibility in asthmatic patients by means of high-resolution computed tomography (HRCT). We studied seven patients (two men, age range 36-69 years)...
C Taube et al.
Respiratory medicine, 97(5), 568-577 (2003-05-09)
The aim of the present study was to assess the reproducibility of changes in forced inspiratory volumes after bronchodilator inhalation. Thirteen patients with chronic obstructive pulmonary disease (COPD) (FEV1, 32-75%pred) and 10 patients with asthma (FEV1, 43-75%pred) inhaled either 200...
Željko Skoko et al.
Journal of the American Chemical Society, 132(40), 14191-14202 (2010-09-24)
The anticholinergic agent oxitropium bromide possesses rich crystal chemistry, most remarkably exhibiting a strong thermosalient effect ("jumping crystal" effect), a mechanical property with potential applications in organic-based actuators. The thermosalient effect, manifested in forceful jumps of up to several centimeters...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.